These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38185603)

  • 1. Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management.
    Manuelyan Z; Butt E; Parupudi S
    Dis Mon; 2024 Jan; 70(1S):101674. PubMed ID: 38185603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Behçet's disease: a review.
    Skef W; Hamilton MJ; Arayssi T
    World J Gastroenterol; 2015 Apr; 21(13):3801-12. PubMed ID: 25852265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS; Choi EK; Heo NY; Hong SC; Myung SJ; Yang SK; Kim JH; Song JK; Yoo B; Yu CS
    Dis Colon Rectum; 2007 May; 50(5):672-6. PubMed ID: 17216141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
    Kim DH; Cheon JH
    Yonsei Med J; 2016 Jan; 57(1):22-32. PubMed ID: 26632379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
    BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of Behçet's disease with various gastrointestinal findings.
    Tominaga K; Kamimura K; Takahashi K; Yokoyama J; Terai S
    Clin J Gastroenterol; 2018 Oct; 11(5):354-358. PubMed ID: 29667077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of intestinal Behçet's disease.
    Hisamatsu T; Naganuma M; Matsuoka K; Kanai T
    Clin J Gastroenterol; 2014 Jun; 7(3):205-12. PubMed ID: 24883128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab).
    Lee JH; Kim TN; Choi ST; Jang BI; Shin KC; Lee SB; Shim YR
    Korean J Intern Med; 2007 Mar; 22(1):24-7. PubMed ID: 17427642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic findings of gastrointestinal involvement in Chinese patients with Behcet's disease.
    Zou J; Shen Y; Ji DN; Zheng SB; Guan JL
    World J Gastroenterol; 2014 Dec; 20(45):17171-8. PubMed ID: 25493032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated treatment strategies for intestinal Behçet's disease.
    Park YE; Cheon JH
    Korean J Intern Med; 2018 Jan; 33(1):1-19. PubMed ID: 29207867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
    Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
    Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal manifestations of Behçet's disease: advances in evaluation and management.
    Vaiopoulos AG; Sfikakis PP; Kanakis MA; Vaiopoulos G; Kaklamanis PG
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S140-8. PubMed ID: 25268668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
    Park J; Cheon JH
    Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report.
    Hassard PV; Binder SW; Nelson V; Vasiliauskas EA
    Gastroenterology; 2001 Mar; 120(4):995-9. PubMed ID: 11231954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An incomplete form of childhood Behçet's disease treated with infliximab.
    Caporuscio S; Pranteda G; Nistico S; Maucione T; Canzoni M; Stefani A; Muscianese M; Fanto M; Sorgi M
    Int J Immunopathol Pharmacol; 2014; 27(3):445-8. PubMed ID: 25280037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms.
    Rhee SH; Kim YB; Lee ES
    J Korean Med Sci; 2005 Dec; 20(6):971-6. PubMed ID: 16361807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Management of Intestinal Behçet's Disease: A Perspective From Gastroenterologists.
    Cheon JH
    J Rheum Dis; 2021 Jan; 28(1):4-16. PubMed ID: 37476392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behçet's disease.
    Wong RC; Ellis CN; Diaz LA
    Int J Dermatol; 1984; 23(1):25-32. PubMed ID: 6373632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the diagnosis, treatment, and prognosis of intestinal Behçet's disease.
    Cheon JH; Kim WH
    Curr Opin Rheumatol; 2015 Jan; 27(1):24-31. PubMed ID: 25405821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.